Nothing Special   »   [go: up one dir, main page]

Product logins

Find logins to all Clarivate products below.


Blog

Here you will find relevant articles and insight into all Clarivate related products and news.

Featured posts

Increasing your likelihood of success in dealmaking discussions Increasing your likelihood of success in dealmaking discussions
Blog March 15, 2022
Increasing your likelihood of success in dealmaking discussions
Beyond animal testing: the rise of organs-on-chips technology Beyond animal testing: the rise of organs-on-chips technology
Blog March 15, 2022
Beyond animal testing: the rise of organs-on-chips technology
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot? Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Blog March 15, 2022
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
From Acquisition to Efficiency: Buchanan’s Seamless Journey with Clarivate IP Admin Services From Acquisition to Efficiency: Buchanan’s Seamless Journey with Clarivate IP Admin Services
Blog March 15, 2022
From Acquisition to Efficiency: Buchanan’s Seamless Journey with Clarivate IP Admin Services
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
Blog March 15, 2022
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
Biotech financing’s rebound: How high will it go? Biotech financing’s rebound: How high will it go?
Blog March 15, 2022
Biotech financing’s rebound: How high will it go?
Early diagnosis in Alzheimer’s disease: A first step towards better care Early diagnosis in Alzheimer’s disease: A first step towards better care
Blog March 15, 2022
Early diagnosis in Alzheimer’s disease: A first step towards better care
chevron_left
chevron_right
Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts
Blog March 15, 2022
Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Blog March 15, 2022
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Pulsed field ablation re-energizes the atrial fibrillation market Pulsed field ablation re-energizes the atrial fibrillation market
Blog March 15, 2022
Pulsed field ablation re-energizes the atrial fibrillation market
CMS enters drug price negotiation arena in sea change for industry CMS enters drug price negotiation arena in sea change for industry
Blog March 15, 2022
CMS enters drug price negotiation arena in sea change for industry
Beyond transparent pricing: decoding the strategies of major PBMs Beyond transparent pricing: decoding the strategies of major PBMs
Blog March 15, 2022
Beyond transparent pricing: decoding the strategies of major PBMs
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Blog March 15, 2022
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Six trends to watch for the global Medtech industry Six trends to watch for the global Medtech industry
Blog March 15, 2022
Six trends to watch for the global Medtech industry
What GLP-1 drugs mean for medtech What GLP-1 drugs mean for medtech
Blog March 15, 2022
What GLP-1 drugs mean for medtech